Objavljeni radovi

11.12.2025.

Imaging analysis of adenovirus particles during the cell entry and intracellular trafficking. Isabela Drašković, Lucija Lulić Horvat, Ksenija Božinović, Dragomira Majhen. Adenoviral Vectors for Gene Therapy (Third Edition) 2025, Pages 501-544.

NGR-bearing human adenovirus type 5 infects cells in flotillin- or caveolin-mediated manner depending on the NGR insertion site. Božinović K, Nestić D, Grellier E, Raddi N, Cornilleau G, Ambriović-Ristov A, Benihoud K, Majhen D. Biomater Adv. 2023 Nov 3;155:213681. doi: 10.1016/j.bioadv.2023.213681. Online ahead of print. PMID: 37944448

Nanoparticle-Based Adjuvants and Delivery Systems for Modern Vaccines. Filipić B, Pantelić I, Nikolić I, Majhen D, Stojić-Vukanić Z, Savić S, Krajišnik D.Vaccines (Basel). 2023 Jun 29;11(7):1172. doi: 10.3390/vaccines11071172.

Human Adenovirus Type 26 Infection Mediated by αvβ3 Integrin Is Caveolin-1-Dependent. Nestić D, Custers J, Švec D, Majhen D.Microbiol Spectr. 2022 Aug 4:e0109722. doi: 10.1128/spectrum.01097-22. Online ahead of print.

Development of a low-seroprevalence, αvβ6 integrin-selective virotherapy based on human adenovirus type 10. Bates EA, Davies JA, Váňová J, Nestić D, Meniel VS, Koushyar S, Cunliffe TG, Mundy RM, Moses E, Uusi-Kerttula HK, Baker AT, Cole DK, Majhen D, Rizkallah PJ, Phesse T, Chester JD, Parker AL.Mol Ther Oncolytics. 2022 Mar 16;25:43-56. doi: 10.1016/j.omto.2022.03.007. eCollection 2022 Jun 16.

Human Adenovirus Type 26 Induced IL-6 Gene Expression in an αvβ3 Integrin- and NF-κB-Dependent Manner. Nestić D, Božinović K, Drašković I, Kovačević A, van den Bosch J, Knežević J, Custers J, Ambriović-Ristov A, Majhen D.Viruses. 2022 Mar 24;14(4):672. doi: 10.3390/v14040672.

Human adenovirus type 26 basic biology and its usage as vaccine vector. Majhen D.Rev Med Virol. 2022 Mar 12:e2338. doi: 10.1002/rmv.2338.

The Revolving Door of Adenovirus Cell Entry: Not All Pathways Are Equal. Nestić D, Božinović K, Pehar I, Wallace R, Parker AL, Majhen D.Pharmaceutics. 2021 Sep 29;13(10):1585. doi: 10.3390/pharmaceutics13101585.

Rational Vaccine Design in Times of Emerging Diseases: The Critical Choices of Immunological Correlates of Protection, Vaccine Antigen and Immunomodulation. Schijns V, Majhen D, van der Ley P, Thakur A, Summerfield A, Berisio R, Nativi C, Fernández-Tejada A, Alvarez-Dominguez C, Gizurarson S, Zamyatina A, Molinaro A, Rosano C, Jakopin Ž, Gursel I, McClean S.Pharmaceutics. 2021 Apr 6;13(4):501. doi: 10.3390/pharmaceutics13040501.

Identification of folate receptor α (FRα) binding oligopeptides and their evaluation for targeted virotherapy applications. Hulin-Curtis SL, Davies JA, Nestić D, Bates EA, Baker AT, Cunliffe TG, Majhen D, Chester JD, Parker AL.Cancer Gene Ther. 2020 Nov;27(10-11):785-798. doi: 10.1038/s41417-019-0156-0.

Endocitoza adenovirusa i urođeni imunosni odgovor